Filed: 7/14/2025ACC: 0001381843-25-000006
📋 What this filing means
ATLE FUND MANAGEMENT AB filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $233.66M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$233.66M
Total AUM (reported)
4.30M
Total Shares
Allocation by class
COM$193.14M82.7%
COM NEW$14.53M6.2%
SPONSORED ADS$10.36M4.4%
SHS$6.50M2.8%
SPON ADS$4.59M2.0%
ORDINARY SHARES$2.85M1.2%
COMMON STOCK$1.69M0.7%
Portfolio Concentration
Top 3$59.87M25.6%
4–10$73.18M31.3%
11–25$76.47M32.7%
Rest$24.13M10.3%
Top 3 weight
25.6%
Top 10 weight
56.9%
Voting Authority Distribution
Total shares with voting rights: 233.66M
Sole
Full voting authority
233.66M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings37
Rows:
Eli Lilly & Co
SOLEShares38.72K
TypeSH
Market value$30.18M
12.92%
Sole
30.18M
Shared
0.00
None
0.00
AbbVie Inc
SOLEShares86.93K
TypeSH
Market value$16.14M
6.91%
Sole
16.14M
Shared
0.00
None
0.00
Boston Scientific Corp
SOLEShares126.19K
TypeSH
Market value$13.55M
5.80%
Sole
13.55M
Shared
0.00
None
0.00
Neurocrine Biosciences Inc
SOLEShares88.39K
TypeSH
Market value$11.11M
4.75%
Sole
11.11M
Shared
0.00
None
0.00
Merck & Co. Inc
SOLEShares139.17K
TypeSH
Market value$11.02M
4.71%
Sole
11.02M
Shared
0.00
None
0.00
Stryker Corporation
SOLEShares27.47K
TypeSH
Market value$10.87M
4.65%
Sole
10.87M
Shared
0.00
None
0.00
Vertex Pharmaceuticals Inc
SOLEShares24.33K
TypeSH
Market value$10.83M
4.64%
Sole
10.83M
Shared
0.00
None
0.00
Intuitive Surgical Inc
SOLEShares18.56K
TypeSH
Market value$10.09M
4.32%
Sole
10.09M
Shared
0.00
None
0.00
Thermo Fisher Scientific Corp
SOLEShares24.27K
TypeSH
Market value$9.84M
4.21%
Sole
9.84M
Shared
0.00
None
0.00
Cencora Inc
SOLEShares31.47K
TypeSH
Market value$9.44M
4.04%
Sole
9.44M
Shared
0.00
None
0.00
Gilead Sciences Inc
SOLEShares73.17K
TypeSH
Market value$8.11M
3.47%
Sole
8.11M
Shared
0.00
None
0.00
Bridgebio Pharma Inc
SOLEShares165.48K
TypeSH
Market value$7.15M
3.06%
Sole
7.15M
Shared
0.00
None
0.00
Amgen Inc
SOLEShares23.89K
TypeSH
Market value$6.67M
2.86%
Sole
6.67M
Shared
0.00
None
0.00
Alkermes PLC
SOLEShares227.22K
TypeSH
Market value$6.50M
2.78%
Sole
6.50M
Shared
0.00
None
0.00
BeiGene Ltd
SOLEShares24.39K
TypeSH
Market value$5.90M
2.53%
Sole
5.90M
Shared
0.00
None
0.00
Mirum Pharmaceuticals Inc
SOLEShares106.91K
TypeSH
Market value$5.44M
2.33%
Sole
5.44M
Shared
0.00
None
0.00
UFP Technologies Inc
SOLEShares21.89K
TypeSH
Market value$5.34M
2.29%
Sole
5.34M
Shared
0.00
None
0.00
Cardinal Health Inc
SOLEShares26.80K
TypeSH
Market value$4.50M
1.93%
Sole
4.50M
Shared
0.00
None
0.00
Edwards Lifesciences Corp
SOLEShares57.36K
TypeSH
Market value$4.49M
1.92%
Sole
4.49M
Shared
0.00
None
0.00
VERONA PHARMA PLC - ADR
SOLEShares47.10K
TypeSH
Market value$4.45M
1.91%
Sole
4.45M
Shared
0.00
None
0.00
Dexcom Inc
SOLEShares50.87K
TypeSH
Market value$4.44M
1.90%
Sole
4.44M
Shared
0.00
None
0.00
iRhythm Technologies Inc
SOLEShares25.30K
TypeSH
Market value$3.90M
1.67%
Sole
3.90M
Shared
0.00
None
0.00
Soleno Therapeutics Inc
SOLEShares40.53K
TypeSH
Market value$3.40M
1.45%
Sole
3.40M
Shared
0.00
None
0.00
Merus N.V.
SOLEShares59.89K
TypeSH
Market value$3.15M
1.35%
Sole
3.15M
Shared
0.00
None
0.00
REVOLUTION Medicines Inc
SOLEShares82.28K
TypeSH
Market value$3.03M
1.30%
Sole
3.03M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Eli Lilly & CoSOLE | COM | 38.72K | SH | $30.18M 12.92% | 30.18M | 0.00 | 0.00 |
AbbVie IncSOLE | COM | 86.93K | SH | $16.14M 6.91% | 16.14M | 0.00 | 0.00 |
Boston Scientific CorpSOLE | COM | 126.19K | SH | $13.55M 5.80% | 13.55M | 0.00 | 0.00 |
Neurocrine Biosciences IncSOLE | COM | 88.39K | SH | $11.11M 4.75% | 11.11M | 0.00 | 0.00 |
Merck & Co. IncSOLE | COM | 139.17K | SH | $11.02M 4.71% | 11.02M | 0.00 | 0.00 |
Stryker CorporationSOLE | COM | 27.47K | SH | $10.87M 4.65% | 10.87M | 0.00 | 0.00 |
Vertex Pharmaceuticals IncSOLE | COM | 24.33K | SH | $10.83M 4.64% | 10.83M | 0.00 | 0.00 |
Intuitive Surgical IncSOLE | COM NEW | 18.56K | SH | $10.09M 4.32% | 10.09M | 0.00 | 0.00 |
Thermo Fisher Scientific CorpSOLE | COM | 24.27K | SH | $9.84M 4.21% | 9.84M | 0.00 | 0.00 |
Cencora IncSOLE | COM | 31.47K | SH | $9.44M 4.04% | 9.44M | 0.00 | 0.00 |
Gilead Sciences IncSOLE | COM | 73.17K | SH | $8.11M 3.47% | 8.11M | 0.00 | 0.00 |
Bridgebio Pharma IncSOLE | COM | 165.48K | SH | $7.15M 3.06% | 7.15M | 0.00 | 0.00 |
Amgen IncSOLE | COM | 23.89K | SH | $6.67M 2.86% | 6.67M | 0.00 | 0.00 |
Alkermes PLCSOLE | SHS | 227.22K | SH | $6.50M 2.78% | 6.50M | 0.00 | 0.00 |
BeiGene LtdSOLE | SPONSORED ADS | 24.39K | SH | $5.90M 2.53% | 5.90M | 0.00 | 0.00 |
Mirum Pharmaceuticals IncSOLE | COM | 106.91K | SH | $5.44M 2.33% | 5.44M | 0.00 | 0.00 |
UFP Technologies IncSOLE | COM | 21.89K | SH | $5.34M 2.29% | 5.34M | 0.00 | 0.00 |
Cardinal Health IncSOLE | COM | 26.80K | SH | $4.50M 1.93% | 4.50M | 0.00 | 0.00 |
Edwards Lifesciences CorpSOLE | COM | 57.36K | SH | $4.49M 1.92% | 4.49M | 0.00 | 0.00 |
VERONA PHARMA PLC - ADRSOLE | SPONSORED ADS | 47.10K | SH | $4.45M 1.91% | 4.45M | 0.00 | 0.00 |
Dexcom IncSOLE | COM NEW | 50.87K | SH | $4.44M 1.90% | 4.44M | 0.00 | 0.00 |
iRhythm Technologies IncSOLE | COM | 25.30K | SH | $3.90M 1.67% | 3.90M | 0.00 | 0.00 |
Soleno Therapeutics IncSOLE | COM | 40.53K | SH | $3.40M 1.45% | 3.40M | 0.00 | 0.00 |
Merus N.V.SOLE | COM | 59.89K | SH | $3.15M 1.35% | 3.15M | 0.00 | 0.00 |
REVOLUTION Medicines IncSOLE | COM | 82.28K | SH | $3.03M 1.30% | 3.03M | 0.00 | 0.00 |
Page 1 of 2